Across TCGA pan-cancer cohorts, CNP Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CNP data layer compared with 21 for mass-spec protein and 6 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher CNP Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CNP expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
COAD and UCEC are the cancer types where CNP Mutation most reproducibly stratifies survival.